📰 Twist Bioscience News
Page 41 - Twist Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Twist Bioscience. Real-time updates on events, politics, business and more.
March 5, 2021
Healthy Outlook COVID-19 is expected to accelerate the growth of the bioscience sector in the state. The race to develop COVID-19 vaccines, therapies and diagnostics has spurred strong growth in the life-sciences sector. Portland and other areas of the state are emerging as hubs for bioscience companies. Portland was the fastest-growing market for life-sciences employment and research and development between 2016 and 2019. The recent move by Twist Bioscience, a Bay Area biotech company, to ...
February 25, 2021
Posted on 323 Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the Twist NGS Methylation Detection System, a robust, end-to-end sample preparation and target enrichment solution for identifying methylated regions in the human genome. DNA methylation plays a key role in many biological proces...
February 24, 2021
Twist Bioscience Corp (NASDAQ: TWST) has launched its NGS Methylation Detection System, end-to-end sample preparation, and target enrichment ...
February 23, 2021
Gene Synthesis Market to 2025 - Global Analysis and Forecasts By Products & Services, Application, End User tipFebruary 23, 2021 Gene Synthesis Market The global gene synthesis market estimated to grow at a CAGR of 28.7% during the forecast period from 2018 to 2025. The gene synthesis market was valued at USD 2,866.1 Mn in 2017 and is estimated to reach US$ 20,122.3 Mn by 2025. A new market report by The Insight Partners on the Market has been released with reliable information and accurate fo...
February 22, 2021
Twist Bioscience and Berry Genomics to offer new NGS solution to advance research and precision medicine Industry News: Twist Bioscience and Berry Genomics to offer new NGS solution to advance research and precision medicine The combined offering is designed to provide researchers with high quality tools to diagnose cancer and selected genetic disease 22 Feb 2021 Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its si...
February 18, 2021
Twist Bioscience and Victorian Clinical Genetic Services Collaborate on Development of Novel Whole Exome Capture Diagnostic Assay - Focus on Rare Disease Prenatal and Pediatric Genetic Screening Services - SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Victorian Clinical Genetic Services (VCGS), an Australian-based speciali...
February 18, 2021
Ark Innovation ETF (ARKK) wasnt quite an overnight sensation, but it quickly made up for lost time after a relatively quiet beginning in 2014. Portfolio manager Cathie Wood founded Ark Investment Management after successful stints at Capital Group, Jennison Group, Tupelo Capital Management, and AllianceBernstein. Wood and her colleagues look for companies that lead, enable, or benefit from disruptive innovation, an approach to business strategy popularized by Clayton Christensen and his colleag...
February 17, 2021
Biotech Sector Blooms Shutterstock A surge of investments in biotech companies could prove crucial to the state’s budding biotech sector and economic recovery. Once relegated to the realm of science fiction, the ability to manipulate a genetic sequence has become a reality. With the potential to eliminate chronic diseases, treat cancer without radiation and grow vital organs in a lab, the biotech sector has become one of the state�...
February 10, 2021
Clinical laboratories prepare for coronavirus variants Adam Bonislawski, 360Dx NEW YORK – As new variants of SARS-CoV-2 continue to emerge, clinical labs are having to develop new and evolve existing approaches to test for the virus. While existing molecular tests appear to be capable of detecting the new UK and South Africa SARS-Cov-2 strains that have been the focus of much recent attention and concern, the appearance of these and other variants could require changes in labs testing process...
February 5, 2021
Search jobs Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2021 ended December 31, 2020. “We reported a strong quarter both for orders and revenu...